KC, Wichita investors, new backers boost Novel Capital’s efforts to break down funding barriers

July 19, 2022  |  Startland News Staff

Additional funders have joined a seed extension round to help Novel Capital accelerate growth for B2B predictable revenue companies, the company announced Monday, noting further investment by KCRise Fund and Wichita-based Tenzing Capital.

Novel Capital’s latest funding round was led by Ulu Ventures, with additional participation from MatterScale and Edovate Capital, as well as its regional investors, Tenzing and KCRise. Financial details of the seed extension were undisclosed, although the company in March announced $115 million in initial equity and debt funding.

The startup offers an alternative approach to traditional funding — offering a simple, transparent, and less risky alternative to bank debt. Among the ways Novel works to accelerate companies’ growth:

  • Bridge between funding rounds to unlock new milestones for higher valuations
  • Immediately invest in sales and marketing resources for revenue growth
  • Hire more staff to meet the needs of new clients
  • Ease predictable cash shortages in seasonal or cyclical businesses
Darcy Howe and Ed Frindt, KCRise Fund

Darcy Howe and Ed Frindt, KCRise Fund

“[We] see the need for financing which isn’t venture and isn’t a bank loan,” said Darcy Howe, founder and managing director of KCRise Fund, voicing confidence in Novel’s model. “The majority of businesses built in the U.S. which are growing are somewhere in the middle.  It’s important that innovation in capital markets bring much needed fuel to power companies in new creative ways.”

Novel’s Revenue Growth Platform helps B2B founders not only leverage their predictable revenue for on-demand access to non-dilutive capital, but also to gain data-driven insights about their key barriers to revenue growth, the company explained in a press release. The platform then pairs companies with machine learning-powered recommendations and actionable strategies to overcome those barriers.

The Novel Capital team — led by co-founders Carlos Antequera, CEO, and Keith Harrington, managing director — and its Revenue Growth Platform are already making a significant impact, said Josh Oeding, founder and general partner at Tenzing Capital, noting his excitement at the prospect of further investment in the startup.

“Recurring revenue has become the 8th wonder of the world.  Entrepreneurs globally are building companies of significance with recurring revenue business models, yet traditional capital markets aren’t suited to meet their needs,” Oeding said. “As experienced founders, Carlos and Keith know first-hand the challenges of navigating the capital markets while building high-growth companies.”

Click here to learn more about Novel’s platform.

“Early-stage founders have passion and an idea, but they’re still learning how to build their business. If they can identify their growth barriers and have the capital and strategies to overcome them, they will build businesses that can overcome any market challenge,” said Carlos Antequera, CEO of Novel Capital. “The additional funding will accelerate the development of our Revenue Growth Platform and empower more businesses to achieve their next level of success.”

Click here to follow or connect with Novel Capital on LinkedIn.

[adinserter block="4"]

2022 Startups to Watch

    stats here

    Related Posts on Startland News

    KC among the best cities to find a job

    By Tommy Felts | May 20, 2015

    The City of Fountains is apparently overflowing with job opportunities. Career data Glassdoor recently named Kansas City, Mo. as the No. 2 city to find employment. Kansas City currently has nearly 28,800 employment opportunities, a median base salary $46,000 and median home value of $138,500. Glassdoor determined the final rankings by looking at hiring opportunity…

    Recap: Bill would gut Kansas Bioscience Authority

    By Tommy Felts | May 19, 2015

    A bill in the Kansas legislature if passed would dissolve the Kansas Bioscience Authority, which has recently served as a venture capital organization investing in early-stage bioscience firms. The measure — SB 305 — would shut down the organization and transfer its funds and obligations to the Kansas Department of Commence. Proponents of the KBA say…

    Kansas City named a top tech locale

    By Tommy Felts | May 19, 2015

    Kansas City again was touted as a top tech destination. Tech publication PC Magazine recently named Kansas City as one of “13 high-tech cities you’ll want to call home.” The magazine noted Kansas City’s access to Google Fiber, its low cost of living and communities such as the Kansas City Startup Village as reasons to…

    Flow Forward Medical raises additional $1.3M

    By Tommy Felts | May 18, 2015

    Flow Forward Medical boosted its latest funding round to further develop its device that helps improve outcomes for hemodialysis patients. The Olathe-based company closed a $1.3 million round of additional Series A financing led by the Kansas Bioscience Authority. Flow Forward previously raised $4.4 million, bringing its total funding raised to date to about $5.7 million.…